Michael Myers
Chief Executive Officer bij QUOIN PHARMACEUTICALS, LTD.
Vermogen: - $ op 29-02-2024
Profiel
Founder of Quoin Pharmaceuticals Ltd., Michael Myers is a businessperson who has been the head of 7 different companies and is Chairman & Chief Executive Officer at this company and Chief Executive Officer & Director at Quoin Pharmaceuticals, Inc. (a subsidiary of Quoin Pharmaceuticals Ltd.), President & Chief Executive Officer of Innocoll Pharmaceuticals Ltd.
and President & Chief Executive Officer at Innocoll Technologies Ltd.
Dr. Myers is also on the board of Wellesley Pharmaceuticals LLC, Sonoran Biosciences, Inc. and SquareX Pharmaceuticals Corp.
Michael Myers previously occupied the position of President-Drug Delivery Division at West Pharmaceutical Services, Inc., President, Chief Executive Officer & Director at Innocoll Holdings, Inc., President, Chief Executive Officer & Director at Innocoll, Inc., President & Chief Executive Officer of Innocoll AG and President-Pharmaceutical Operations at Fuisz Technologies Ltd.
He received a doctorate from University College Cork.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
QUOIN PHARMACEUTICALS, LTD.
16.82% | 26-10-2023 | 561 480 000 ( 16.82% ) | - $ | 29-02-2024 |
Actieve functies van Michael Myers
Bedrijven | Functie | Begin |
---|---|---|
QUOIN PHARMACEUTICALS, LTD. | Chief Executive Officer | 28-10-2021 |
Innocoll Pharmaceuticals Ltd.
Innocoll Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Innocoll Pharmaceuticals Ltd. engages in pharmaceutical preparations. The company was founded on June 1, 2005 and is headquartered in Dublin, Ireland. | Chief Executive Officer | - |
Innocoll Technologies Ltd.
Innocoll Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Innocoll Holdings Plc, Innocoll Technologies Ltd. is an Irish company located in Athlone that engages in research and experimental development on natural sciences and engineering. Michael Myers is the current CEO of the firm. | Chief Executive Officer | - |
Wellesley Pharmaceuticals LLC
Wellesley Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wellesley Pharmaceuticals LLC develops and markets drugs for treating Nocturia. The company was founded by David A. Dill in 2011 and is headquartered in Newtown, PA. | Director/Board Member | - |
Sonoran Biosciences, Inc. | Director/Board Member | - |
Quoin Pharmaceuticals, Inc.
Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | Chief Executive Officer | - |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Director/Board Member | 01-11-2022 |
Eerdere bekende functies van Michael Myers
Bedrijven | Functie | Einde |
---|---|---|
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | Chief Executive Officer | 01-01-2015 |
Fuisz Technologies Ltd.
Fuisz Technologies Ltd. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Fuisz Technologies Ltd. is a private company that develops and commercializes rapid dissolving tablets for over-the-counter and prescription pharmaceuticals. The company is based in Chantilly, VA. Fuisz Technologies was acquired by Biovail Corp. on November 12, 1999 for $145.48 million. | Corporate Officer/Principal | 01-01-1999 |
░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Michael Myers
University College Cork | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
WEST PHARMACEUTICAL SERVICES, INC. | Health Technology |
Bedrijven in privébezit | 11 |
---|---|
Fuisz Technologies Ltd.
Fuisz Technologies Ltd. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Fuisz Technologies Ltd. is a private company that develops and commercializes rapid dissolving tablets for over-the-counter and prescription pharmaceuticals. The company is based in Chantilly, VA. Fuisz Technologies was acquired by Biovail Corp. on November 12, 1999 for $145.48 million. | Health Technology |
Innocoll Holdings, Inc.
Innocoll Holdings, Inc. Pharmaceuticals: MajorHealth Technology Innocoll Holdings, Inc. manufactures pharmaceutical products. The company is based in Ashburn, VA. | Health Technology |
Wellesley Pharmaceuticals LLC
Wellesley Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wellesley Pharmaceuticals LLC develops and markets drugs for treating Nocturia. The company was founded by David A. Dill in 2011 and is headquartered in Newtown, PA. | Health Technology |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | Health Technology |
Innocoll Pharmaceuticals Ltd.
Innocoll Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Innocoll Pharmaceuticals Ltd. engages in pharmaceutical preparations. The company was founded on June 1, 2005 and is headquartered in Dublin, Ireland. | Health Technology |
Innocoll AG
Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Innocoll Technologies Ltd.
Innocoll Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Innocoll Holdings Plc, Innocoll Technologies Ltd. is an Irish company located in Athlone that engages in research and experimental development on natural sciences and engineering. Michael Myers is the current CEO of the firm. | Commercial Services |
Sonoran Biosciences, Inc. | |
Quoin Pharmaceuticals, Inc.
Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | Health Technology |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Health Technology |
Quoin Pharmaceuticals Ltd. |